OptTest
Database showing the most common legal and regulatory barriers to HIV testing, linkage to care and treatment access across Europe and in each individual European country, including how they affect particular key populations.
EATG » OptTest
Newsletter / News bulletin
Latest news
Combination therapy found to be more effective in treating patients with leishmaniasis and HIV
The results of clinical trials conducted in Ethiopia by the Drugs for Neglected Diseases initiative (DNDi), in partnership with Médecins Sans Frontières (MSF), the University of Gondar, and Addis Ababa University, open…
Read moreEfavirenz in pregnancy is at least as safe as other antiretrovirals
No safety signal for raltegravir either An individual patient data analysis of almost 25,000 pregnancies in women living with HIV has found that the rate of birth defects following exposure…
Read moreECDC: Hepatitis A – Annual epidemiological report for 2016
The European Centre for Disease Prevention and Control (ECDC) released the Hepatitis A – Annual epidemiological report for 2016. The report can be downloaded here.
Read moreLatest projects
EFOEUPATI – Ensuring the future of EUPATI beyond 2020
Project aims: To ensure the sustainability of the results of the EUPATI project, to develop sustainable models of collaboration to ensure this, and put into place the infrastructure required for…
PARADIGM – Patients Active in Research and Dialogues for an Improved Generation of Medicines
Project aims: To provide a framework that allows structured, meaningful, sustainable and ethical patient engagement throughout three key decision-making points of the development of medicinal products: (i) the research priority…
HIV Outcomes – Beyond Viral Suppression
Initiative aims: HIV Outcomes, is a multi-stakeholder initiative developing and communicating expert, evidence based consensus recommendations for policy makers focused on the provision and delivery of high quality of care…
